Wang He

5.1k total citations
129 papers, 3.5k citations indexed

About

Wang He is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Wang He has authored 129 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Molecular Biology, 34 papers in Surgery and 27 papers in Cancer Research. Recurrent topics in Wang He's work include Bladder and Urothelial Cancer Treatments (24 papers), Cancer-related molecular mechanisms research (17 papers) and RNA modifications and cancer (15 papers). Wang He is often cited by papers focused on Bladder and Urothelial Cancer Treatments (24 papers), Cancer-related molecular mechanisms research (17 papers) and RNA modifications and cancer (15 papers). Wang He collaborates with scholars based in China, United States and Hong Kong. Wang He's co-authors include Tianxin Lin, Guangzheng Zhong, Changhao Chen, Xu Chen, Jian Huang, Bo Wang, Qingqing Cai, Ning Jiang, Wen Dong and Jian Huang and has published in prestigious journals such as Advanced Materials, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Wang He

124 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wang He China 31 2.2k 1.5k 592 525 430 129 3.5k
Hongtao Liu China 32 2.0k 0.9× 1.1k 0.8× 720 1.2× 299 0.6× 712 1.7× 96 3.5k
Leonard C. Edelstein United States 26 2.2k 1.0× 1.5k 1.0× 678 1.1× 208 0.4× 810 1.9× 49 3.9k
Xin Hu China 28 2.2k 1.0× 884 0.6× 342 0.6× 126 0.2× 237 0.6× 96 3.1k
Dan Sun China 30 2.1k 0.9× 974 0.7× 329 0.6× 105 0.2× 238 0.6× 126 3.1k
Geoffrey W. Krissansen New Zealand 35 1.6k 0.7× 433 0.3× 533 0.9× 224 0.4× 922 2.1× 109 3.4k
Blair Madison United States 24 2.1k 1.0× 687 0.5× 776 1.3× 671 1.3× 710 1.7× 38 3.4k
Wanjun Chen China 32 1.5k 0.7× 475 0.3× 637 1.1× 230 0.4× 1.3k 3.0× 50 3.5k
Jean‐Jacques Michaille France 24 2.2k 1.0× 1.8k 1.2× 179 0.3× 132 0.3× 633 1.5× 38 3.3k
Ziwen Zhu China 24 1.2k 0.5× 590 0.4× 598 1.0× 161 0.3× 747 1.7× 81 2.5k

Countries citing papers authored by Wang He

Since Specialization
Citations

This map shows the geographic impact of Wang He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wang He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wang He more than expected).

Fields of papers citing papers by Wang He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wang He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wang He. The network helps show where Wang He may publish in the future.

Co-authorship network of co-authors of Wang He

This figure shows the co-authorship network connecting the top 25 collaborators of Wang He. A scholar is included among the top collaborators of Wang He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wang He. Wang He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Feng, Tian Chi, Yanting Ji, et al.. (2025). An Efficient Biosynthetic System for Developing Functional Silk Fibroin‐Based Biomaterials (Adv. Mater. 7/2025). Advanced Materials. 37(7).
2.
Chen, Siyu, Deyu Tu, Wang He, et al.. (2025). Genetically engineered sericin hydrogels for the delivery of human adiponectin in treating ulcerative colitis in mice. Acta Biomaterialia. 202. 216–233.
3.
Wang, Fangyu, Siyu Chen, Deyu Tu, et al.. (2025). Biosynthesis of a dual growth factors (GFs) functionalized silk sericin hydrogel to promote chronic wound healing in diabetic mice. Bioactive Materials. 52. 511–528. 1 indexed citations
4.
Niu, Shaoxi, et al.. (2024). Suitability of the MP1000 Platform for Robot-assisted Prostatectomy: A Prospective Randomised Controlled Trial. European Urology Open Science. 64. 2–8. 3 indexed citations
6.
Wang, Bo, Xi Sun, Xiaodong Huang, et al.. (2024). Type III interferon inhibits bladder cancer progression by reprogramming macrophage-mediated phagocytosis and orchestrating effective immune responses. Journal for ImmunoTherapy of Cancer. 12(4). e007808–e007808. 10 indexed citations
7.
Wang, Bo, Honghui Zeng, Wang He, et al.. (2024). NAD+ metabolism enzyme NNMT in cancer-associated fibroblasts drives tumor progression and resistance to immunotherapy by modulating macrophages in urothelial bladder cancer. Journal for ImmunoTherapy of Cancer. 12(7). e009281–e009281. 10 indexed citations
8.
Wang, Feng, Tian Chi, Yanting Ji, et al.. (2024). An Efficient Biosynthetic System for Developing Functional Silk Fibroin‐Based Biomaterials. Advanced Materials. 37(7). e2414878–e2414878. 16 indexed citations
10.
Dong, Yan, Qingqing He, Meihua Yang, et al.. (2023). The APC/C E3 ligase subunit ANAPC11 mediates FOXO3 protein degradation to promote cell proliferation and lymph node metastasis in urothelial bladder cancer. Cell Death and Disease. 14(8). 516–516. 9 indexed citations
11.
Li, Kaiwen, Yishan Zhang, Jintao Hu, et al.. (2023). Singe intraoperative instillation of chemotherapy during radical cystectomy for bladder cancer: Oncological outcome and survival predictors. Cancer Medicine. 12(11). 12084–12094. 1 indexed citations
12.
Liu, Feng, Binbin Cui, Yanfen Wu, et al.. (2021). Correlation of Serum Adropin Levels with Risk Factors of Cardiovascular Disease in Hemodialysis Patients. Metabolic Syndrome and Related Disorders. 19(7). 401–408. 9 indexed citations
13.
Zhang, Xiaokang, Baoxin Li, Na Li, et al.. (2020). Changes of serum Adropin protein and neprilysin levels in patients with type 2 diabetic retinopathy and analysis of influening factors. SHILAP Revista de lepidopterología. 1 indexed citations
14.
Gu, Jingyao, Pei Liu, Wang He, et al.. (2020). <p>Long Non-Coding RNA SPRY4-IT1 Reverses Cisplatin Resistance by Downregulating MPZL-1 via Suppressing EMT in NSCLC</p>. OncoTargets and Therapy. Volume 13. 2783–2793. 17 indexed citations
15.
Tian, Tian, Xiaobin Lv, Guokai Pan, et al.. (2019). Long Noncoding RNA MPRL Promotes Mitochondrial Fission and Cisplatin Chemosensitivity via Disruption of Pre-miRNA Processing. Clinical Cancer Research. 25(12). 3673–3688. 60 indexed citations
16.
Zhang, Zhongyuan, Yu Fan, Cheng Shen, et al.. (2019). DDD score for renal tumor: An intuitive and comprehensive anatomical scoring system to access the outcomes of retroperitoneal laparoscopic partial nephrectomy. International Journal of Urology. 26(4). 451–456. 6 indexed citations
17.
Chen, Xu, Ruihui Xie, Peng Gu, et al.. (2018). Long Noncoding RNA LBCS Inhibits Self-Renewal and Chemoresistance of Bladder Cancer Stem Cells through Epigenetic Silencing of SOX2. Clinical Cancer Research. 25(4). 1389–1403. 180 indexed citations
18.
Mei, Mei, et al.. (2018). Comparison of echocardiography and 64‐slice spiral computed tomography in the diagnosis of congenital heart disease in children. Journal of Cellular Biochemistry. 120(3). 3969–3977. 7 indexed citations
19.
He, Wang, et al.. (2012). Introduction of the Rs-AFP2 gene into Eucalyptus urophylla for resistance to Phytophthora capsici.. JOURNAL OF TROPICAL FOREST SCIENCE. 24(2). 198–208. 9 indexed citations
20.
Hu, Shangying, Wang He, Wen Chen, Yanping Wu, & You‐Lin Qiao. (2009). Serological epidemiology study of HPV-6,11,16,18 in Shanxi rural women. Zhonghua weishengwuxue he mianyixue zazhi. 29(8). 701–705. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026